One of our engineers will be in touch with you within 1 business day, typically within a few hours. Please add @equilibar.com to your safe senders list to ensure proper delivery of our emails.
Oligonucleotide drugs are made up of short sections of genetic sequences and are used to target disorders in the genetic code. The first drug of this type was used in 1998 during the AIDS epidemic. Since then, the field has accelerated rapidly and today many oligonucleotide drugs are in clinical trials, promising improvements in treatment Read More